NYSE:BTX Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis $7.36 +0.07 (+0.96%) As of 07/3/2025 03:30 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendHeadlinesSEC FilingsTrendsBuy This Stock About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BTX alerts:Sign Up Key Stats Today's Range$7.29▼$7.3750-Day Range$6.27▼$7.4452-Week Range$5.10▼$8.31Volume488,490 shsAverage Volume751,620 shsMarket Capitalization$432.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA. Read More Receive BTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address BTX Stock News HeadlinesWhy We Love to Buy “Freshly Cut” Dividends (3 Yielding Up to 13.6%)...July 4 at 10:04 PM | marketbeat.comBrooklyn ImmunoTherapeutics (NYSE:BTX) Stock Price Down 0.3% - Time to Sell?July 2 at 2:11 AM | americanbankingnews.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.July 5 at 2:00 AM | Brownstone Research (Ad)I'm Passing On The YieldMax ETFs – 4 Monthly Pay Stocks With 11% and Higher Yields Will Do FineJune 29, 2025 | 247wallst.comBlackRock Technology and Private Equity Term Trust (BTX) Commences Tender Offer for up to 50% of outstanding common sharesJune 9, 2025 | businesswire.comBlackRock Announces Shareholder Approval of Strategy Changes to the BlackRock Technology and ...April 17, 2025 | gurufocus.comBrooklyn Nets News, Videos, Schedule, Roster, Stats - Yahoo SportsSeptember 15, 2024 | sports.yahoo.com'Brooklyn Nine-Nine' star Andre Braugher dies at 61December 19, 2023 | abcnews.go.comSee More Headlines BTX Stock Analysis - Frequently Asked Questions How have BTX shares performed this year? Brooklyn ImmunoTherapeutics' stock was trading at $0.2940 at the beginning of 2025. Since then, BTX shares have increased by 2,403.4% and is now trading at $7.36. How do I buy shares of Brooklyn ImmunoTherapeutics? Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Brooklyn ImmunoTherapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Brooklyn ImmunoTherapeutics investors own include Mastech Digital (MHH), Altimeter Growth Corp. 2 (AGCB), African Gold Acquisition (AGAC), Aldel Financial (ADF), Adit EdTech Acquisition (ADEX) and Mega Matrix (ACY). Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry Television Broadcasting Sub-IndustryN/A Current SymbolNYSE:BTX CIK748592 WebN/A Phone(212) 582-1199FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$40.69 million Price / Sales10.64 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares58,826,000Free FloatN/AMarket Cap$432.96 million OptionableNo Data Beta4.61 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NYSE:BTX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Brooklyn ImmunoTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.